212
Views
4
CrossRef citations to date
0
Altmetric
Clinical Features

Transition of Patients with COPD Across Different Care Settings: Challenges and Opportunities for Hospitalists

, MD, FCCP, FACP
Pages 176-185 | Published online: 13 Mar 2015

References

  • . World Health Organization. Chronic obstructive pulmonary disease (COPD). Fact sheet no. 315. http://www.who.int/mediacentre/factsheets/fs315/en. November 2011. Accessed August 5, 2011
  • . O'Donnell DE, Hernandez P, Kaplan A, . Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease—2008 update—highlights for primary care. Can Respir J. 2008;15( suppl A):1A–8A
  • . Miniño AM, Xu JQ, Kochanek KD. Deaths: preliminary data for 2008. Natl Vital Stat Rep. 2010;59(2):1–52
  • . Chronic obstructive pulmonary disease. In: Schraufnagel DE, Kell B, eds. Breathing in America: Diseases, Progress, and Hope. New York, NY: American Thoracic Society; 2010:47–56. http://www.thoracic.org/education/breathing-in-america.pdf. Accessed August 5, 2011
  • . World Health Organization. Tobacco. Fact sheet no. 339. http://www.who.int/mediacentre/factsheets/fs339/en/index.html. July 2011. Accessed May 13, 2011
  • . Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of COPD. http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Updated December 2010. Accessed August 5, 2011
  • . Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest. 2000;117( 2 suppl):1S–4S
  • . Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet. 1997;349(9064):1498–1504
  • . Brown DW, Croft JB, Greenlund KJ, Giles WH. Trends in hospitalization with chronic obstructive pulmonary disease—United States, 1990–2005. COPD. 2010;7(1):59–62
  • . Chuang C, Levine SH, Rich J. Enhancing cost-effective care with a patient-centric coronary obstructive pulmonary disease program. Popul Health Manag. 2011;14(3):133–136
  • . Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007;4(7):502–506
  • . Centers for Disease Control and Prevention (CDC). Deaths from chronic obstructive pulmonary disease—United States, 2000–2005. MMWR Morb Mortal Wkly Rep. 2008;57(45):1229–1232
  • . Foreman MG, Zhang L, Murphy J, ; COPDGene Investigators. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med. 2011;184(4):414–420
  • . American Thoracic Society; European Respiratory Society. Standards for the diagnosis and management of patients with COPD. http://www.copd-ats-ers.org/copddoc.pdf. Published 2004. Accessed August 5, 2011
  • . Wier LM, Elixhauser A, Pfuntner A, Au DH; Healthcare Cost and Utilization Project. Overview of hospitalizations among patients with COPD, 2008. Statistical brief #106. http://www.hcup-us.ahrq.gov/reports/statbriefs/sbl06.jsp. February 2011. Accessed August 5, 2011
  • . Halpin DM, Miravitlles M. Chronic obstructive pulmonary disease: the disease and its burden to society. Proc Am Thorac Soc. 2006;3(7):619–623
  • . National Institutes of Health; National Heart, Lung, and Blood Institute. Morbidity and mortality: 2009 chartbook on cardiovascular, lung, and blood diseases. http://www.nhlbi.nih.gov/resources/docs/2009_Chart-Book.pdf. Published October 2009. Accessed August 5, 2011
  • . Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360(14):1418–1428
  • . Zook CJ, Moore FD. High-cost users of medical care. N Engl J Med. 1980;302(18):996–1002
  • . Friedman B, Basu J. The rate and cost of hospital readmissions for preventable conditions. Med Care Res Rev. 2004;61(2):225–240
  • . McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest. 2007;132(6):1748–1755
  • . Yip NH, Yuen G, Lazar EJ, . Analysis of hospitalizations for COPD exacerbation: opportunities for improving care. COPD. 2010;7(2):85–92
  • . Bourbeau J, Julien M, Maltais F, ; Chronic Obstructive Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche en Santé du Québec. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med. 2003;163(5):585–591
  • . Tougaard L, Krone T, Sorknaes A, Ellegaard H. Economic benefits of teaching patients with chronic obstructive pulmonary disease about their illness. The PASTMA Group. Lancet. 1992;339(8808):1517–1520
  • . Dewan NA, Rice KL, Caldwell M, Hilleman DE. Economic evaluation of a disease management program for chronic obstructive pulmonary disease. COPD. 2011;8(3):153–159
  • . Casas A, Troosters T, Garcia-Aymerich J, ; members of the CHRONIC Project. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J. 2006;28(1):123–130
  • . The Society of Hospital Medicine. SHM fact sheet: about hospital medicine, http://www.hospitalmedicine.org/AM/Template.cfm?Section=Media_Kit&Template=/CM/ContentDisplay.cfm&ContentID=26269. Updated July 12, 2010. Accessed August 5, 2011
  • . Kuo YF, Sharma G, Freeman JL, Goodwin JS. Growth in the care of older patients by hospitalists in the United States. N Engl J Med. 2009;360(11):1102–1112
  • . White HL, Glazier RH. Do hospitalist physicians improve the quality of inpatient care delivery? A systematic review of process, efficiency and outcome measures. BMC Med. 2011;9(1):58
  • . Beckman H. Three degrees of separation. Ann Intern Med. 2009;151(12):890–891
  • . Fletcher KE, Underwood W 3rd, Davis SQ, Mangrulkar RS, McMahon LF Jr, Saint S. Effects of work hour reduction on residents' lives: a systematic review. JAMA. 2005;294(9):1088–1100
  • . Sehgal NL, Shah HM, Parekh VI, Roy CL, Williams MV. Non-housestaff medicine services in academic centers: models and challenges. J Hosp Med. 2008;3(3):247–255
  • . Saint S, Flanders SA. Hospitalists in teaching hospitals: opportunities but not without danger. J Gen Intern Med. 2004;19(4):392–393
  • . Wilensky GR. Reforming Medicare's physician payment system. N Engl J Med. 2009;360(7):653–655
  • . US Department of Health and Human Services. Hospital compare, http://www.hospitalcompare.hhs.gov/hospital-search.aspx. Updated August 5, 2011. Accessed August 5, 2011
  • . Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006;144(12):894–903
  • . Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204
  • . Cazzola M, MacNee W, Martinez FJ, ; American Thoracic Society and European Respiratory Society Task Force on outcomes of COPD. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008;31(2):416–469
  • . Sethi S. Infection as a comorbidity of COPD. Eur Respir J. 2010;35(6):1209–1215
  • . Niewoehner DE. Clinical practice. Outpatient management of severe COPD. N Engl J Med. 2010;362(15):1407–1416
  • . Decramer M, Nici L, Nardini S, . Targeting the COPD exacerbation. Respir Med. 2008;102( suppl 1):S3–S15
  • . Snow V, Lascher S, Mottur-Pilson C; Joint Expert Panel on COPD of the American College of Chest Physicians and the American College of Physicians—Amercian Society of Internal Medicine. The evidence base for management of acute exacerbations of COPD: clinical practice guideline, part 1. Chest. 2001;119(4):1185–1189
  • . Flanders SA, Podnizik PM, Whelan C, Blaum C. Acute hospital care. In: Halter JB, Ouslander J, Tinetti M, , eds. Hazzard's Geriatric Medicine and Gerontology. 6th ed. New York, NY: McGraw Hill; 2009:209–220
  • . Shorr AF, Sun X, Johannes RS, Yaitanes A, Tabak YP. Validation of a novel risk score for severity of illness in acute exacerbations of COPD. Chest. 2011;140(5):1177–1183
  • . Zoia MC, Corsico AG, Beccaria M, . Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management. Respir Med. 2005;99(12):1568–1575
  • . Quon BS, Gan WQ, Sin DD. Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis. Chest. 2008;133(3):756–766
  • . Niewoehner DE, Erbland ML, Deupree RH, . Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med. 1999;340(25):1941–1947
  • . Hurst JR, Wedzicha JA. Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review. BMC Med. 2009;7:40
  • . Rodriguez-Roisin R, Lloyd-Owen S, Wedzicha JA. Exacerbations of COPD. Timely Topics in Medicine, http://www.ttmed.com Prous Science; 2003
  • . Aaron SD, Vandemheen KL, Hebert P, . Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med. 2003;348(26):2618–2625
  • . Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA. 2010;303(23):2359–2367
  • . Poole PJ, Chacko E, Wood-Baker RW, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;(1):CD002733
  • . Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med. 1998;158(16):1769–1776
  • . Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med. 2010;182(3):325–331
  • . Donaldson GC, Wedzicha JA. COPD exacerbations .1: Epidemiology. Thorax. 2006;61(2):164–168
  • . Gruffydd-Jones K, Langley-Johnson C, Dyer C, Badlan K, Ward S. What are the needs of patients following discharge from hospital after an acute exacerbation of chronic obstructive pulmonary disease (COPD)? Prim Care Respir J. 2007;16(6):363–368
  • . van Walraven C, Mamdani M, Fang J, Austin PC. Continuity of care and patient outcomes after hospital discharge. J Gen Intern Med. 2004;19(6):624–631
  • . Barr RG, Celli BR, Mannino DM, . Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med. 2009;122(4):348–355
  • . National Jewish Health. Self-management plan. Action to take when you experience increased symptoms, http://www.nationaljewish.org/pdf/copd_action_plan.pdf. Accessed August 5, 2011
  • . Coleman EA. The Care Transitions Program. What will it take to ensure high quality transitional care? http://www.caretransitions.org/What_will_it_take.asp. 2011. Accessed August 5, 2011
  • . Wong JD, Bajcar JM, Wong GG, . Medication reconciliation at hospital discharge: evaluating discrepancies. Ann Pharmacother. 2008;42(10):1373–1379
  • . Marciniuk D, Goodridge D, Hernandez P, ; Canadian Thoracic Society COPD Committee Dyspnea Expert Writing Group. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J. 2011;18(2):69–78
  • . Lareau SC, Yawn BP. Improving adherence with inhaler therapy in COPD. Int J Chron Obstruct Pulmon Dis. 2010;5:401–406
  • . Davis PA, Hahn J, Hoffman GJ, . Congressional Research Service. Medicare provisions in the patient protection and affordable care act (PPACA):summary and timeline. http://www.njha.com/Reform/Pdf/CRSMedicarePPACA_4%282%29.pdf. Published June 30, 2010. Accessed August 5, 2011
  • . Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA. 2007;297(8):831–841
  • . Pham HH, Grossman JM, Cohen G, Bodenheimer T. Hospitalists and care transitions: the divorce of inpatient and outpatient care. Health Aff (Millwood). 2008;27(5):1315–1327
  • . Haynes RB. The teaching of patient education concepts on therapeutic compliance to medical students. Bull N Y Acad Med. 1985;61(2):123–134
  • . Hurst JR, Vestbo J, Anzueto A, ; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138
  • . Dudas V, Bookwalter T, Kerr KM, Pantilat SZ. The impact of follow-up telephone calls to patients after hospitalization. Am J Med. 2001;111(9B):26S–30S
  • . Sharma G, Kuo YF, Freeman JL, Zhang DD, Goodwin JS. Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease. Arch Intern Med. 2010;170(18):1664–1670
  • . Obojski A, Chmielowicz B, Panaszek B. Hospital management of patients with exacerbation of severe and very severe chronic obstructive pulmonary disease (COPD)—protocol of treatment and discharge. Am J Respir Crit Care Med. 2011;183:A3119
  • . Garvey C, Fromer L, Saver DF, Yawn BP. Pulmonary rehabilitation: an underutilized resource in primary COPD care. Phys Sportsmed. 2010;38(4):54–60
  • . Marciniuk DD, Brooks D, Butcher S, ; Canadian Thoracic Society COPD Committee Expert Working Group. Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease—practical issues: a Canadian Thoracic Society Clinical Practice Guideline. Can Respir J. 2010;17(4):159–168
  • . Albert RK, Connett J, Bailey WC, ; COPD Clinical Research Network. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011;365(8):689–698
  • . Pannu KD. Azithromycin 250 mg daily reduces exacerbation frequency and improves quality of life in selected COPD patients [published online ahead of print October 13, 2011]. Thorax.
  • . Pomares X, Montón C, Espasa M, Casabon J, Monsó E, Gallego M. Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations. Int J Chron Obstruct Pulmon Dis. 2011;6:449–456
  • . Seemungal TA, Wilkinson TM, Hurst JR Perera WR Sapsford RJ, Wedzicha JA. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med. 2008;178(11):1139–1147
  • . Daliresp (roflumilast) tablets [package insert]. St. Louis, MO: Forest Pharmaceuticals, Inc.; 2011
  • . Chong J, Poole P, Leung B, Black PN. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;(5):CD002309
  • . Celli BR, Cote CG, Marin JM, . The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012
  • . Martinez FJ, Foster G, Curtis JL, ; NETT Research Group. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med. 2006;173(12):1326–1334
  • . Martinez FJ, Han MK, Andrei AC, ; National Emphysema Treatment Trial Research Group. Longitudinal change in the BODE index predicts mortality in severe emphysema. Am J Respir Crit Care Med. 2008;178(5):491–499
  • . Farkas J, Kosnik M, Flezar M, Suskovic S, Lainscak M. Self-rated health predicts acute exacerbations and hospitalizations in patients with COPD. Chest. 2010;138(2):323–330

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.